Discontinuation report LESCOL XL

Last updated on 2020-04-17 History
Report ID 109153
Drug Identification Number 02250527
Brand name LESCOL XL
Common or Proper name LESCOL XL 80MG 2X14
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) FLUVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 2X14
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date 2020-04-03
Actual discontinuation date 2020-04-03
Remaining supply date 2020-04-03
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-04-17 French Compare
v3 2020-04-17 English Compare
v2 2020-03-20 French Compare
v1 2020-03-20 English Compare